Bioequivalency
Mostrando 1-2 de 2 artigos, teses e dissertações.
-
1. Planning and control of projects in a center of bioequivalence / Planejamento e controle de projetos em um centro de bioequivalencia
At the same time globalization forces national markets to be more competitive, customers have more options of products and services, and therefore become more demand of improved quality and reduced prices. In the pharmaceutical industry as a consequence, bioequivalence centers have to adapt to this relatively new scenery to provide more qualified products wi
Publicado em: 2009
-
2. Safety and bioequivalency of three formulations of respiratory syncytial virus-enriched immunoglobulin.
Respiratory syncytial virus (RSV) causes serious illness (lower respiratory illness) in preterm infants. RSV antibody-enriched immunoglobulin (RSVIG) that was lyophilized (LYO) protected against RSV lower respiratory illness. The Food and Drug Administration now requires an additional viral inactivation step (VI). We compared LYO, LYO-VI, and a more convenie